B. Kirsch, J. DuBois, and D. Chadha, “A Multi-Center, Open-Label Study to Assess Pharmacokinetics (PK), Safety and Tolerability of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, ≥9 to <17 Years of Age, with Axillary Hyperhidrosis”, J of Skin, vol. 3, p. S54, Nov. 2019.